Susquehanna International Group, LLP Adaptive Biotechnologies Corp Call Options Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$3.37 - $5.12 $104,807 - $159,232	31,100 New	31,100 $159,000
Q4 2023 Feb 14, 2024	SELL	$3.46 - $5.33 $7,266 - $11,193	-2,100 Reduced 10.34%	18,200 $89,000
Q3 2023 Nov 14, 2023	BUY	$5.07 - $8.44 $38,532 - $64,143	7,600 Added 59.84%	20,300 $110,000
Q2 2023 Aug 11, 2023	SELL	$6.19 - $8.78 $2,476 - $3,511	-400 Reduced 3.05%	12,700 $85,000
Q1 2023 May 16, 2023	SELL	$7.8 - $10.11 $4.38 Million - $5.68 Million	-561,900 Reduced 97.72%	13,100 $115,000
Q4 2022 Feb 14, 2023	BUY	$6.26 - $9.34 $3.44 Million - $5.13 Million	549,700 Added 2172.73%	575,000 $4.39 Million
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $92,950 - $181,181	14,300 Added 130.0%	25,300 $180,000
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $116,480 - $268,086	-18,200 Reduced 62.33%	11,000 $89,000
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $191,267 - $546,210	18,900 Added 183.5%	29,200 $405,000
Q3 2021 Nov 15, 2021	SELL	$30.02 - $39.87 $678,452 - $901,062	-22,600 Reduced 68.69%	10,300 $350,000
Q2 2021 Aug 11, 2021	BUY	$32.22 - $44.59 $483,300 - $668,850	15,000 Added 83.8%	32,900 $1.34 Million
Q1 2021 May 17, 2021	SELL	$37.26 - $67.74 $5.82 Million - $10.6 Million	-156,300 Reduced 89.72%	17,900 $721,000
Q4 2020 Feb 16, 2021	SELL	$45.01 - $65.47 $13,503 - $19,641	-300 Reduced 0.17%	174,200 $10.3 Million
Q3 2020 Nov 16, 2020	BUY	$35.79 - $48.81 $4.26 Million - $5.81 Million	119,000 Added 214.41%	174,500 $8.49 Million
Q2 2020 Aug 14, 2020	BUY	$24.95 - $48.38 $785,925 - $1.52 Million	31,500 Added 131.25%	55,500 $2.69 Million
Q1 2020 May 15, 2020	BUY	$16.96 - $34.16 $178,080 - $358,679	10,500 Added 77.78%	24,000 $667,000
Q4 2019 Feb 14, 2020	SELL	$24.56 - $32.8 $1.25 Million - $1.67 Million	-50,900 Reduced 79.04%	13,500 $404,000
Q3 2019 Nov 14, 2019	BUY	$30.31 - $53.51 $1.95 Million - $3.45 Million	64,400 New	64,400 $1.99 Million

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

Viking Global Investors LP

30M
Shares

$170 Million
0.59% of portfolio
Rubric Capital Management LP New York, NY

14.4M
Shares

$81.8 Million
2.05% of portfolio
Black Rock Inc. New York, NY

11.7M
Shares

$66.3 Million
0.0% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

11.6M
Shares

$65.9 Million
0.56% of portfolio
Vanguard Group Inc Valley Forge, PA

10.6M
Shares

$60.4 Million
0.0% of portfolio

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $812M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account